Home
Glenmark Pharmaceuticals Ltd Board of Directors
Board of Directors at Glenmark Pharmaceuticals Ltd
B Saldanha
Non Executive Director
Cheryl Pinto
Executive Director (Corporate)
Dipankar Bhattacharjee
Independent Non Exe. Director
Glenn Saldanha
Chairman & Managing Director
Rajesh Desai.
Independent Non Exe. Director
Key Highlights
- Glenn Saldanha joins the board as Chairman / Executive Director / M D / Promoter, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Cheryl Pinto joins the board as ED / WTD / Promoter, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Anurag Mantri joins the board as ED / President / Global CFO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- B E Saldanha continues to serve as the Non Executive Director in 2025, maintaining the same position as in the previous year.
- Sona Saira Ramasastry continues to serve as the Independent Non Exe. Director in 2025, maintaining the same position as in the previous year.
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 27 Oct 2025 | 1812.15 |
| 24 Oct 2025 | 1818.5 |
| 23 Oct 2025 | 1849.85 |
| 21 Oct 2025 | 1855.7 |
| 20 Oct 2025 | 1852.85 |
| 17 Oct 2025 | 1861.25 |
| 16 Oct 2025 | 1865.3 |
| 15 Oct 2025 | 1893.1 |
| 14 Oct 2025 | 1893.8 |
| 13 Oct 2025 | 1911.1 |
Company Fundamentals for Glenmark Pharmaceuticals Ltd
Market Cap
51,139 Cr
EPS
47.3
P/E Ratio (TTM)
38.3
P/B Ratio (TTM)
5.8
Day’s High
1844.9
Day’s Low
1800.0
DTE
0.3
ROE
14.9
52 Week High
2286.15
52 Week Low
1274.7
ROCE
16.8
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24
Document
Popular Search
FAQs for Board of Directors of Glenmark Pharmaceuticals Ltd
How are members of Glenmark Pharmaceuticals Ltd Board of Directors selected?
Members of the Glenmark Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Glenmark Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Glenmark Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Glenmark Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Glenmark Pharmaceuticals Ltd Board of Directors meet?
The Glenmark Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Glenmark Pharmaceuticals Ltd Board of Directors?
The Glenmark Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Glenmark Pharmaceuticals Ltd?
The current Board of Directors at Glenmark Pharmaceuticals Ltd includes Glenn Saldanha( Chairman / Executive Director / M D / Promoter) ,Cheryl Pinto( ED / WTD / Promoter) ,Anurag Mantri( ED / President / Global CFO) ,B E Saldanha( Non Executive Director) ,Sona Saira Ramasastry( Independent Non Exe. Director) . The full list can be found on Glenmark Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
